Depression drug trial halted early – what we know
NCT ID NCT06011577
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study tested a new drug called REL-1017 as an extra treatment for adults with major depression who didn't get enough help from standard antidepressants. The trial was stopped early and included only 27 participants. The main goal was to see if the drug could reduce depression symptoms over 28 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Relmada Site
Dothan, Alabama, 36303, United States
-
Relmada Site
Homewood, Alabama, 35209, United States
-
Relmada Site
Anaheim, California, 92805, United States
-
Relmada Site
Lafayette, California, 94549, United States
-
Relmada Site
Newport Beach, California, 92660, United States
-
Relmada Site
Orange, California, 92868, United States
-
Relmada Site
Redlands, California, 92374, United States
-
Relmada Site
Sherman Oaks, California, 91403, United States
-
Relmada Site
Farmington, Connecticut, 06030, United States
-
Relmada Site
Brandon, Florida, 33511, United States
-
Relmada Site
Hialeah, Florida, 33027, United States
-
Relmada Site
Jacksonville, Florida, 32256, United States
-
Relmada Site
Miami, Florida, 33133, United States
-
Relmada Site
Miami, Florida, 33174, United States
-
Relmada Site
Okeechobee, Florida, 34972, United States
-
Relmada Site
Tampa, Florida, 33607, United States
-
Relmada Site
Springfield, Illinois, 62794, United States
-
Relmada Site
Baltimore, Maryland, 21208, United States
-
Relmada Site
Mankato, Minnesota, 56001, United States
-
Relmada Site
Toms River, New Jersey, 08755, United States
-
Relmada Site
Brooklyn, New York, 11235, United States
-
Relmada Site
Cedarhurst, New York, 11516, United States
-
Relmada Site
New York, New York, 10036, United States
-
Relmada Site
Philadelphia, Pennsylvania, 19104, United States
-
Relmada Site
Franklin, Tennessee, 37067, United States
-
Relmada Site
Memphis, Tennessee, 38119, United States
-
Relmada Site
Austin, Texas, 78712, United States
-
Relmada Site
Bellaire, Texas, 77401, United States
-
Relmada Site
Friendswood, Texas, 77546, United States
-
Relmada Site
Houston, Texas, 77030, United States
-
Relmada Site
Wichita Falls, Texas, 76309, United States
-
Relmada Site
Clinton, Utah, 84015, United States
-
Relmada Site
Draper, Utah, 84020, United States
-
Relmada Site
Rutland, Vermont, 05701, United States
-
Relmada Site
Charlottesville, Virginia, 22903, United States
-
Relmada Site
Seattle, Washington, 98104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can a structured care pathway ease teen depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can a nasal spray break through tough depression?